Qianqian Huang
Luzhou, 646000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Epigallocatechin promotes megakaryocyte differentiation via ERα-dependent SRC/PI3K/AKT signaling for thrombocytopenia treatment.
Journal: Journal of ethnopharmacology
Published: February 13, 2026
Ginkgolic acid: a novel IL1R1 agonist facilitating megakaryocyte differentiation and platelet production via the SRC/MEK/ERK pathway.
Journal: International immunopharmacology
Published: August 27, 2025
Reactive oxygen species: Orchestrating the delicate dance of platelet life and death.
Journal: Redox biology
Published: November 16, 2024
Reliability assessment model for multiple stress factors accelerated degradation test using a Wiener process with random effects.
Journal: PloS one
Published: November 14, 2024
Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/JNK pathway through a potential target of 5-HTR2A.
Journal: Phytotherapy research : PTR
Published: February 20, 2024
Targeting CD38/ ADP-ribosyl cyclase as a novel therapeutic strategy for identification of three potent agonists for leukopenia treatment.
Journal: Pharmacological research
Published: October 20, 2023
Xanthotoxin, a novel inducer of platelet formation, promotes thrombocytopoiesis via IL-1R1 and MEK/ERK signaling.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 17, 2023
The Application of Ethnomedicine in Modulating Megakaryocyte Differentiation and Platelet Counts.
Journal: International journal of molecular sciences
Published: November 29, 2022
Rapid Profiling of Metabolites Combined with Network Pharmacology to Explore the Potential Mechanism of Sanguisorba officinalis L. against Thrombocytopenia.
Journal: Metabolites
Published: October 19, 2022
Methyl Gallate Alleviates Acute Ulcerative Colitis by Modulating Gut Microbiota and Inhibiting TLR4/NF-κB Pathway.
Journal: International journal of molecular sciences
Published: September 29, 2022
Sanguisorba officinalis L. suppresses non-small cell lung cancer via downregulating the PI3K/AKT/mTOR signaling pathway based on network pharmacology and experimental investigation.
Journal: Frontiers in pharmacology
Published: September 27, 2022
Last Updated: 09/26/2026